D, L., YM, R., L, D. B., SR, V., P, S., V, S., . . . A, N. (2012). Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: Results from a multicenter prospective registry. Journal of the American College of Cardiology (JACC), 59(13), 1168.
Chicago Style (17th ed.) CitationD, Lakkireddy, et al. "Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation: Results from a Multicenter Prospective Registry." Journal of the American College of Cardiology (JACC) 59, no. 13 (2012): 1168.
MLA (9th ed.) CitationD, Lakkireddy, et al. "Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation: Results from a Multicenter Prospective Registry." Journal of the American College of Cardiology (JACC), vol. 59, no. 13, 2012, p. 1168.
